Ceragem Medisys

Cheonan, South Korea Founded: 2005 • Age: 21 yrs Acquired By Green Cross Medical Systems
Point-of-care diagnostics for metabolic disorders and photodynamic therapy are developed.

About Ceragem Medisys

Ceragem Medisys is a company based in Cheonan (South Korea) founded in 2005 was acquired by Green Cross Medical Systems in April 2015.. Ceragem Medisys operates in a competitive market with competitors including Jana Care, Telcare, Intuity Medical, Hygieia and Ascensia, among others.

  • Headquarter Cheonan, South Korea
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Ceragem Medisys

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Ceragem Medisys

Ceragem Medisys has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Green Cross Medical Systems. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
In vitro diagnostics kits, reagents and devices
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Ceragem Medisys

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Ceragem Medisys

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Ceragem Medisys Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Ceragem Medisys

Ceragem Medisys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jana Care, Telcare, Intuity Medical, Hygieia and Ascensia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Mobile-based diagnostics for diabetes prevention and management are provided.
domain founded_year HQ Location
Diabetes is managed via cellular technology and social networking.
domain founded_year HQ Location
An all-in-one blood glucose monitoring system is developed and offered.
domain founded_year HQ Location
Insulin dosage guidance for diabetes is provided via handheld devices.
domain founded_year HQ Location
Provides blood glucose monitoring systems and diabetes care solutions worldwide.
domain founded_year HQ Location
Blood glucose monitoring systems and clinical chemistry analyzers are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Ceragem Medisys

Frequently Asked Questions about Ceragem Medisys

When was Ceragem Medisys founded?

Ceragem Medisys was founded in 2005.

Where is Ceragem Medisys located?

Ceragem Medisys is headquartered in Cheonan, South Korea. It is registered at Cheonan, Chungcheongnam-do, South Korea.

What does Ceragem Medisys do?

CERAGEM Medisys operates as a subsidiary of Ceragem Peru S.A.C and is focussed on developing in vitro diagnostic products. In April 2015, CERAGEM Medisys merged into GreenCross group and renamed as Green Cross Medis. As of 13 Sep 2016, company offers glycated hemoglobin (HbA1c) analyzers (CERA-STAT 2000 and Labona Check A1c) that employ the principles of boronate affinity method; electrochemical blood glucose monitoring systems (CERA-CHEK 1Code, CERA-CHEK 1070, CERA-CHEK wing, CERA-CHEK GOLD; pets glucose monitoring system (CERA-PET ); hemoglobin testing system (CERA-CHEK Hb Plus); and personal light therapy device- Ocimple, a device to treat acne.

Who are the top competitors of Ceragem Medisys?

Ceragem Medisys's top competitors include i-SENS, Telcare and Jana Care.

Who are Ceragem Medisys's investors?

Ceragem Medisys has 1 investor. Key investors include Green Cross Medical Systems.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available